Rua Life Sci. Share News (RUA)

RUA Life Sciences shares jump on strategy update

(Sharecast News) - Shares in RUA Life Sciences rocketed on Monday after the company updated the market on its strategy, focusing on its medical device businesses.

RUA Life Sciences shares soar as testing and new deals progress

(Alliance News) - RUA Life Sciences PLC on Monday said its Contract Manufacture business is growing in scale, and that two of its other businesses have met important testing milestones.

AIM WINNERS & LOSERS: Oriole inks earn-in deals; Velocys sinks

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

AIM WINNERS & LOSERS: Plexus surges as contract value rises

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

RUA Life Sciences shares rise on upbeat trading update

(Alliance News) - RUA Life Sciences PLC on Tuesday said that trading in the first four months of financial year 2024 has met expectations of the company.

UK shareholder meetings calendar - next 7 days

RUA Life Sciences annual revenue grows and loss narrows; shares plunge

(Alliance News) - RUA Life Sciences PLC on Wednesday said full-year revenue grew by double digits on strong performance across its businesses.

IN BRIEF: RUA Life Sciences shares drop after reorganisation

RUA Life Sciences PLC - Glasgow-based medical technology holding company focused on exploiting long-term implantable biostable polyurethane Elast-Eon - Completes reorganisation through "hive down" of vascular graft business to RUA Vascular Ltd and of heart valve business to RUA Structural Heart Ltd, both wholly owned subsidiaries. Company says having introduced segmental reporting, it believes separating business units out from parent's activities will benefit its financial control. Has now decided "to formalise the process" which RUA Life Sciences says will simplify regulatory transparency and increase funding options, alongside other benefits. Reorganisation included the transfer of all related assets including intellectual property. RUA also will recover costs attributable of GBP4.4 million for RUA Vascular and GBP3.1 million for RUA Structural heart. This will remain as an inter-company debt, resulting in a one-off trading profit of around GBP7.5 million for RUA Life Sciences. Company's shares previously jumped up yesterday after it predicted strong annual revenue growth.

IN BRIEF: RUA Life Sciences shares up as revenue expected to jump

RUA Life Sciences PLC - Glasgow-based medical technology holding company - Expects to report year-on-year revenue growth of 34% for the year ended on March 31, with revenue of GBP2.2 million produced from Contract Manufacture, GBP1.6 million, and Biomaterials, GBP554,000. Expects pretax loss to be similar to last year at around GBP2.3 million to GBP2.4 million. For financial 2022, revenue was GBP1.6 million and pretax loss was GBP2.4 million.

RUA Life Sciences, Corcym sign deal to bring vascular grafts to market

(Alliance News) - RUA Life Sciences on Wednesday said it agreed with medical device company Corcym SRL, which focuses on the human heart, to bring RUA's range of large bore vascular grafts to market.

IN BRIEF: RUA Life Sciences confirms half-year loss and revenue

RUA Life Sciences PLC - Glasgow-based medical technology holding company - Confirms pretax loss in the six months that ended September 30 narrowed by 15% to GBP1.1 million from GBP1.3 million a year earlier.

RUA Life Sciences says half-year revenue rises and loss narrows

(Alliance News) - RUA Life Sciences PLC on Monday said its revenue increased in the first half of its financial year following rising sales volumes in the period.

RUA narrows losses after strong first-half sales

(Sharecast News) - Medical device group RUA Life Sciences said in an update on Monday that trading in the first half had been "strong", with revenue ahead of expectations.

RUA Life Sciences shares rise as performance exceeds expectations

(Alliance News) - RUA Life Sciences PLC on Tuesday said performance is ahead of initial budget figures, and it announced new patents and manufacturing agreements.

RUA Life Sciences shares fall as full-year loss widens on higher costs

(Alliance News) - RUA Life Sciences PLC shares fell on Monday after the company reported a widened full-year loss on higher costs due to increased research and development activities.